Related Experiment Video
Updated: May 8, 2026
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Nanotechnology and tumor microcirculation
1Department of Pharmaceutical Biomedicine, Graduate School of Medicine, Dental, and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-Naka, Kita-ku, Okayama 700-8530 Japan.
Abstract:
Though much progress has been made in the development of anti-tumor chemotherapeutic agents, refractoriness is still a major clinical difficulty because little is known about the non-autonomous mechanisms involved. Abnormal capillary structures in tumors, for example, are well documented, but a thorough characterization of microcirculation, including functional consequences with particular regard to drug delivery and intratumor accumulation, is still required for many kinds of tumor. In this review, we highlight how use of synthesized nanoparticles, themselves a product of emerging nanotechnology, are beginning to open up new perspectives in understanding the functional and therapeutic consequences of capillary structure within tumors. Furthermore, nanoparticles promise exciting new clinical applications. I also stress the urgent necessity of developing clinically relevant tumor models, both in vivo and in vitro.
Insights
Synthesized nanoparticles offer new insights into tumor microcirculation and drug delivery, addressing chemotherapy resistance. Further development of clinically relevant tumor models is crucial for advancing cancer treatment.
Area of Science:
- Nanotechnology
- Oncology
- Pharmacology
Background:
- Chemotherapeutic refractoriness remains a significant clinical challenge in cancer treatment.
- Non-autonomous mechanisms, particularly abnormal tumor capillary structures and impaired microcirculation, contribute to poor drug delivery and intratumor accumulation.
- A comprehensive understanding of tumor microcirculation's functional consequences is needed.
Purpose of the Study:
- To review the role of synthesized nanoparticles in understanding tumor capillary structure and its functional and therapeutic implications.
- To explore the potential of nanotechnology in overcoming chemotherapy resistance.
- To emphasize the need for clinically relevant in vivo and in vitro tumor models.
Main Methods:
- Review of current literature on tumor microcirculation, chemotherapy resistance, and nanotechnology applications.
- Analysis of how synthesized nanoparticles can elucidate the functional consequences of abnormal tumor vasculature.
- Discussion on the development of novel therapeutic strategies utilizing nanoparticles.
Main Results:
- Synthesized nanoparticles provide novel perspectives on the relationship between tumor capillary structure and drug delivery efficiency.
- Nanoparticle-based approaches show promise for enhancing intratumor drug accumulation and overcoming refractoriness.
- The review highlights the potential of nanotechnology to revolutionize anti-tumor chemotherapeutic strategies.
Conclusions:
- Nanoparticles are emerging as powerful tools to investigate and potentially overcome challenges posed by tumor microcirculation.
- Further research into nanoparticle-drug conjugates and delivery systems is warranted for improved cancer therapy.
- Development of robust, clinically relevant tumor models is essential for translating these findings into effective treatments.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
02:17The Tumor Microenvironment
01:10Mechanism of Angiogenesis